1. UBE2T regulates FANCI monoubiquitination to promote NSCLC progression by activating EMT
   Jiguang Zhang et al, 2022, Oncology Reports CrossRef
2. Identification and validation of a novel ubiquitination-related gene UBE2T in Ewing’s sarcoma
   Guoxin Qu et al, 2023, Frontiers in Oncology CrossRef
3. Establishment and Verification of a Gene Signature for Diagnosing Type 2 Diabetics by WGCNA, LASSO Analysis, and In Vitro Experiments
   Huaming Shao et al, 2022, BioMed Research International CrossRef
4. Diverse roles of UBE2T in cancer (Review)
   Nengqian Ma et al, 2023, Oncology Reports CrossRef
5. Knockdown of ubiquitin-conjugating enzyme E2T (UBE2T) suppresses lung adenocarcinoma progression via targeting fibulin-5 (FBLN5)
   Yi Li et al, 2022, Bioengineered CrossRef
6. Ubiquitin‑conjugating enzymes as potential biomarkers and therapeutic targets for digestive system cancers (Review)
   Xiangxiang Lei et al, 2023, Oncology Reports CrossRef
7. Effects of Hyperthyroidism on Venous Thromboembolism: A Mendelian Randomization Study
   Fushi Han et al, 2022, Journal of Immunology Research CrossRef
8. The Molecular Basis of Ubiquitin-Conjugating Enzymes (E2s) as a Potential Target for Cancer Therapy
   Xiaodi Du et al, 2021, International Journal of Molecular Sciences CrossRef
9. Upregulation of ubiquitin-conjugating enzyme E2T (UBE2T) predicts poor prognosis and promotes hepatocellular carcinoma progression
   Xiaoyue Ren et al, 2021, Bioengineered CrossRef